Nezemer (Oxymetazoline Hydrochloride)

Oxymetazoline Hydrochloride, the active ingredient in Nezemer, is a alpha‑adrenergic agonist presented as a nasal formulation for nasal use. It relieves nasal congestion associated with the common cold, sinusitis and allergic rhinitis. GNH USA supplies Nezemer as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxymetazoline Hydrochloride is an alpha‑adrenergic agonist that reduces swelling of the nasal mucosa, improving airflow in several upper‑respiratory conditions.

Common cold: reduces nasal blockage and improves breathing during viral upper‑respiratory infections. Sinusitis: alleviates congestion linked to inflamed sinus passages. Allergic rhinitis: diminishes nasal obstruction caused by allergen‑triggered inflammation.

Oxymetazoline Hydrochloride may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nasal irritation or burning sensation - Dryness of the nasal mucosa - Sneezing or mild epistaxis - Headache - Altered taste or smell - Transient mild hypertension

Serious or Rare Side Effects: - Severe hypertension or hypertensive crisis - Cardiac arrhythmias - Rebound nasal congestion (rhinitis medicamentosa) with prolonged use - Nasal ulceration or perforation - Anaphylactic reaction - Ocular irritation if spray contacts the eyes

Before using Oxymetazoline Hydrochloride, consider the following safety measures.

Pregnancy: consult a healthcare professional before use. Breastfeeding: use only if advised by a physician. Age restrictions: avoid in children under six years unless directed. Cardiovascular disease: use with caution in patients with hypertension or heart disease. Concurrent nasal decongestants: do not combine with other topical decongestants to prevent excess vasoconstriction. Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Oxymetazoline Hydrochloride can interact with other medicines; monitor the following.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Other sympathomimetic agents: additive vasoconstrictive effects.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask tachycardia caused by systemic absorption. - Antihypertensive drugs: potential enhancement of blood‑pressure‑lowering effect. - Additional nasal sprays or topical agents: increased risk of local irritation.